+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Trigeminal Neuralgia Therapeutics Market by Therapy Type (Complementary Therapies, Neuromodulation, Pharmacologic), Product Type (Branded, Generic), Mechanism Of Action, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Trigeminal Neuralgia Therapeutics Market by Therapy Type (Complementary Therapies, Neuromodulation, Pharmacologic), Product Type (Branded, Generic), Mechanism Of Action, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Trigeminal Neuralgia Therapeutics Market by Therapy Type (Complementary Therapies, Neuromodulation, Pharmacologic), Product Type (Branded, Generic), Mechanism Of Action, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5367904
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The trigeminal neuralgia therapeutics market is advancing as innovative treatment approaches and emerging technologies reshape care for this complex neuropathic condition. Senior stakeholders are increasingly seeking actionable insight into market dynamics, competitive positioning, and evolving supply chain factors to support critical investment and operational decisions.

Market Snapshot: Trigeminal Neuralgia Therapeutics Market

The Trigeminal Neuralgia Therapeutics Market grew from USD 262.17 million in 2024 to USD 284.26 million in 2025. It is expected to continue growing at a CAGR of 8.03%, reaching USD 416.90 million by 2030. This consistent upward trend is fueled by ongoing advancements in neuromodulation, increased attention to personalized care, and growing regional demand for both innovative therapies and generics. Companies, payers, and providers are closely monitoring supply chain changes, particularly those driven by regulatory shifts and targeted tariffs influencing therapeutic availability and cost.

Scope & Segmentation

  • Therapy Type: Complementary therapies (acupuncture, herbal medicine, physical therapy), pharmacologic treatments (analgesics, muscle relaxants, anticonvulsants), neuromodulation (deep brain stimulation, peripheral nerve stimulation), and surgical procedures (balloon compression, gamma knife radiosurgery, microvascular decompression, radiofrequency ablation).
  • Product Type: Branded (innovator, patented) and generic therapeutic options.
  • Mechanism of Action: Calcium channel blockers, gaba analogues, NMDA receptor antagonists, voltage gated sodium channel blockers.
  • Distribution Channel: Hospital pharmacies, retail pharmacies, online pharmacies.
  • End User: Ambulatory surgical centers, specialty clinics, home care settings, hospitals.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering UK, Germany, France, UAE, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, and major ASEAN economies).
  • Key Companies: Viatris Inc., Biogen Inc., Biohaven Pharmaceuticals Holding Company Ltd., Noema Pharma AG, Pfizer Inc., Novartis Pharmaceuticals Corporation, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Roche Holding AG.

Key Takeaways and Strategic Insights

  • Therapeutic strategies are shifting from reliance on conventional pharmacologics to more integrative and device-driven modalities, enabling greater personalization and reduced adverse events for patients.
  • Clinical adoption of neuromodulation and complementary therapies is expanding, supported by deeper empirical validation and patient demand for holistic pain management.
  • Regulatory harmonization and local sourcing initiatives are influencing how novel agents and devices achieve market entry, especially across emerging regions with cost-sensitive patient populations.
  • Collaborations between academic research institutions and industry are sustaining a robust innovation pipeline in both drug and device classes.
  • Generic and branded manufacturers leverage strategic sourcing and cost-optimization to address growing demand while managing pricing pressures tied to global market forces.

Tariff Impact: Navigating US Tariffs and Supply Chain Complexity

The 2025 United States tariffs have introduced notable uncertainty into the trigeminal neuralgia therapeutics supply chain. Manufacturers of active pharmaceutical ingredients and neuromodulation electrodes that rely on imports are experiencing an uptick in input costs, prompting reevaluation of pricing frameworks and reimbursement negotiations. In response, organizations are adopting localized production and strategic supplier diversification to protect operating margins. Providers and payers are also adapting procurement strategies to sustain access to critical treatments, reflecting cross-functional collaboration to address evolving market challenges.

Methodology & Data Sources

This analysis combines thorough secondary research—including clinical trial, patent, and reimbursement data—alongside expert interviews with neurologists, pain specialists, and regulatory professionals. Validation occurs via data triangulation across multiple sources, with segmentation criteria covering therapy type, product, mechanism, distribution, and end-user categories. Forecasting and scenario planning methodologies ensure resulting insights are actionable and grounded in real-world trends.

Why This Report Matters for Senior Decision-Makers

  • Enables executives to anticipate shifts in market positioning and investment value by providing a detailed breakdown of therapy categories, regional trends, and emerging competition.
  • Supplies actionable recommendations for managing cost pressures, especially in the context of tariff fluctuations and changing supplier landscapes, supporting robust risk management and strategy alignment.
  • Equips leaders with current intelligence on the interplay between innovation, reimbursement models, and clinical adoption, driving sound operational and business development decisions.

Conclusion

The trigeminal neuralgia therapeutics landscape is defined by rapid advancements in treatment strategy, supply chain adaptation, and innovation pipeline growth. Informed decision-making, agile response to regulatory shifts, and a patient-centered approach are critical for sustained success in this dynamic market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of targeted neuromodulation devices improving trigeminal neuralgia pain control
5.2. Advancements in gene therapy approaches targeting trigeminal ganglion for sustained relief
5.3. Integration of AI-driven diagnostic tools for early detection and personalized treatment planning
5.4. Rising adoption of novel monoclonal antibody therapies targeting pain mediators in trigeminal neuralgia
5.5. Growth of minimally invasive radiofrequency ablation for refractory trigeminal neuralgia management in aging populations
5.6. Expansion of telemedicine services enhancing patient access to specialist care for trigeminal neuralgia
5.7. Emerging role of combination therapy protocols integrating pharmacological and neuromodulation modalities
5.8. Pipeline developments in small molecule inhibitors targeting voltage gated sodium channels for pain mitigation
5.9. Increasing focus on quality of life outcomes in clinical trials for trigeminal neuralgia therapies
5.10. Cost effectiveness analyses driving adoption of novel trigeminal neuralgia treatment strategies in healthcare systems
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Trigeminal Neuralgia Therapeutics Market, by Therapy Type
8.1. Introduction
8.2. Complementary Therapies
8.2.1. Acupuncture
8.2.2. Herbal Medicine
8.2.3. Physical Therapy
8.3. Neuromodulation
8.3.1. Deep Brain Stimulation
8.3.2. Peripheral Nerve Stimulation
8.4. Pharmacologic
8.4.1. Analgesics
8.4.2. Anticonvulsants
8.4.2.1. Carbamazepine
8.4.2.2. Gabapentin
8.4.2.3. Lamotrigine
8.4.2.4. Oxcarbazepine
8.4.3. Muscle Relaxants
8.5. Surgical
8.5.1. Balloon Compression
8.5.2. Gamma Knife Radiosurgery
8.5.3. Microvascular Decompression
8.5.4. Radiofrequency Ablation
9. Trigeminal Neuralgia Therapeutics Market, by Product Type
9.1. Introduction
9.2. Branded
9.2.1. Innovator
9.2.2. Patented
9.3. Generic
10. Trigeminal Neuralgia Therapeutics Market, by Mechanism Of Action
10.1. Introduction
10.2. Calcium Channel Blockers
10.3. Gaba Analogues
10.4. Nmda Receptor Antagonists
10.5. Voltage Gated Sodium Channel Blockers
11. Trigeminal Neuralgia Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Trigeminal Neuralgia Therapeutics Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Home Care Settings
12.4. Hospitals
12.5. Specialty Clinics
13. Americas Trigeminal Neuralgia Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Trigeminal Neuralgia Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Trigeminal Neuralgia Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Viatris Inc.
16.3.2. Biogen Inc.
16.3.3. Biohaven Pharmaceuticals Holding Company Ltd.
16.3.4. Noema Pharma AG
16.3.5. Pfizer Inc.
16.3.6. Novartis Pharmaceuticals Corporation
16.3.7. GlaxoSmithKline plc
16.3.8. Sun Pharmaceutical Industries Ltd.
16.3.9. Lupin Pharmaceuticals, Inc.
16.3.10. Roche Holding AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HERBAL MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HERBAL MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PERIPHERAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PERIPHERAL NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY CARBAMAZEPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY CARBAMAZEPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GABAPENTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY OXCARBAZEPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY OXCARBAZEPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BALLOON COMPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BALLOON COMPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GAMMA KNIFE RADIOSURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GAMMA KNIFE RADIOSURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY INNOVATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PATENTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PATENTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GABA ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY GABA ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NMDA RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NMDA RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY VOLTAGE GATED SODIUM CHANNEL BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY VOLTAGE GATED SODIUM CHANNEL BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 152. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 153. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 156. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 157. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 158. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 159. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 160. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 161. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 164. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 165. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 166. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 167. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 178. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 179. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 186. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 187. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PHARMACOLOGIC, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 286. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2018-2024 (USD MILLION)
TABLE 288. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY NEUROMODULATION, 2025-2030 (USD MILLION)
TABLE 289. GERMANY TRIGEMINAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Trigeminal Neuralgia Therapeutics market report include:
  • Viatris Inc.
  • Biogen Inc.
  • Biohaven Pharmaceuticals Holding Company Ltd.
  • Noema Pharma AG
  • Pfizer Inc.
  • Novartis Pharmaceuticals Corporation
  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Roche Holding AG

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 284.26 Million
Forecasted Market Value ( USD ) by 2030 $ 416.9 Million
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Trigeminal Neuralgia Treatment Global Market Report 2025 - Product Image

Trigeminal Neuralgia Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Trigeminal Neuralgia- Pipeline Insight, 2025 - Product Image

Trigeminal Neuralgia- Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Neuralgia Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Delivery Mode (Injectable, Oral, Topical), End User, Distribution Channel, Indication, Drug Class - Global Forecast 2025-2030 - Product Image

Neuralgia Treatment Market by Treatment Type (Non Pharmacological, Pharmacological), Delivery Mode (Injectable, Oral, Topical), End User, Distribution Channel, Indication, Drug Class - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Trigeminal Neuralgia Drug Market

Trigeminal Neuralgia (TN) is a chronic pain disorder that affects the trigeminal nerve, one of the largest nerves in the head. It is characterized by episodes of intense, stabbing pain in the face, usually on one side. Treatment for TN typically involves medications, such as anticonvulsants, antidepressants, and muscle relaxants. These drugs are part of the Central Nervous System (CNS) drug market, which includes drugs used to treat neurological and psychiatric disorders. The CNS drug market is highly competitive, with many large pharmaceutical companies developing and marketing drugs for the treatment of neurological and psychiatric disorders. Companies such as Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis are some of the major players in the CNS drug market. Other companies, such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals, also have a presence in the market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.